These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33599731)

  • 41. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Sexual Dysfunctions in Transgender Persons: Results from the ENIGI Follow-Up Study.
    Kerckhof ME; Kreukels BPC; Nieder TO; Becker-Hébly I; van de Grift TC; Staphorsius AS; Köhler A; Heylens G; Elaut E
    J Sex Med; 2019 Dec; 16(12):2018-2029. PubMed ID: 31668732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
    Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
    J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS.
    Fernandez JD; Tannock LR
    Endocr Pract; 2016 Apr; 22(4):383-8. PubMed ID: 26574790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproductive health in trans and gender diverse patients: Transgender medicine: contextual trans gynecology.
    Trotsenburg MV
    Reproduction; 2024 Nov; 168(5):. PubMed ID: 39269219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals.
    Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandić M; Brismar TB; Dahlqvist Leinhard O; Chanpen S; Flanagan JN; Arver S; Gustafsson T
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31794605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.
    Hazegh K; Bravo MD; Kamel H; Dumont L; Kanias T
    Transfusion; 2020 May; 60(5):947-954. PubMed ID: 32176332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocrinology of Transgender Medicine.
    T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
    Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects on Voice Fundamental Frequency and Satisfaction with Voice in Trans Men during Testosterone Treatment-A Longitudinal Study.
    Nygren U; Nordenskjöld A; Arver S; Södersten M
    J Voice; 2016 Nov; 30(6):766.e23-766.e34. PubMed ID: 26678122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
    Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
    Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of testosterone on ovulatory function in transmasculine individuals.
    Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
    Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approach to the Patient: Pharmacological Management of Trans and Gender-Diverse Adolescents.
    O'Connell MA; Nguyen TP; Ahler A; Skinner SR; Pang KC
    J Clin Endocrinol Metab; 2022 Jan; 107(1):241-257. PubMed ID: 34476487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reproductive functions and fertility preservation in transgender women: a French case series.
    Sermondade N; Benaloun E; Berthaut I; Moreau E; Prades M; Béranger A; Chabbert-Buffet N; Johnson N; Lévy R; Dupont C
    Reprod Biomed Online; 2021 Aug; 43(2):339-345. PubMed ID: 34144898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
    de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
    Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment.
    de Blok CJM; Dijkman BAM; Wiepjes CM; Staphorsius AS; Timmermans FW; Smit JM; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e782-e790. PubMed ID: 33206172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.
    Ory J; Nackeeran S; Balaji NC; Hare JM; Ramasamy AR
    J Urol; 2022 Jun; 207(6):1295-1301. PubMed ID: 35050717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.
    Kinnear HM; Constance ES; David A; Marsh EE; Padmanabhan V; Shikanov A; Moravek MB
    Hum Reprod; 2019 Oct; 34(10):2009-2017. PubMed ID: 31585007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
    Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.